Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Public ClinicalTrials.gov record NCT00522379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, 5-arm, Parallel-group Trial to Assess Rotigotine Transdermal System Dose Response in Subjects With Advanced-stage Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to show Rotigotine dose response at four doses of Rotigotine used with L-dopa in treating advanced stage Parkinson's disease.
Study identification
- NCT ID
- NCT00522379
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 514 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Jul 2011 (Actual)
- Completion
- Jul 2011 (Actual)
- Last update posted
- Oct 27, 2014
2007 – 2011
United States locations
- U.S. sites
- 62
- U.S. states
- 29
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Tuscaloosa | Alabama | — | — |
| Not listed | Gilbert | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Scottsdale | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | Loma Linda | California | — | — |
| Not listed | Oxnard | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Naples | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Pompano Beach | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Sunrise | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Suwanee | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Anderson | Indiana | — | — |
| Not listed | Des Moines | Iowa | — | — |
| Not listed | Kansas City | Kansas | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Golden Valley | Minnesota | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Missoula | Montana | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Commack | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Salisbury | North Carolina | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Greensburg | Pennsylvania | — | — |
| Not listed | Souderton | Pennsylvania | — | — |
| Not listed | Upland | Pennsylvania | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Midvale | Utah | — | — |
| Not listed | South Ogden | Utah | — | — |
| Not listed | Alexandria | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Roanoke | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Kirkland | Washington | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00522379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2014 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00522379 live on ClinicalTrials.gov.